No Data
No Data
Alzamend Neuro Ends ATM Offering, Issues Forward-Looking Statements
Alzamend Neuro Halts Equity Offering Program, Prioritizing Shareholder Value Amid Strategic Shift, Shares Slide
Alzamend Neuro, Inc. (NASDAQ:ALZN) made waves Tuesday when the company announced its decision to terminate its "at-the-market" equity offering program. Shares were down nearly 12% at last check. What
Express News | Alzamend Neuro Shares Are Trading Lower After the Company Announced the Termination Its At-the-market Equity Offering Program
Express News | Alzamend Neuro Announces Termination of at-the-Market Equity Offering Program
12 Health Care Stocks Moving In Friday's After-Market Session
GainersNeuBase Therapeutics (NASDAQ:NBSE) stock increased by 11.1% to $0.45 during Friday's after-market session. The market value of their outstanding shares is at $1.6 million. Aptevo Therapeutics (
Alzamend Neuro And 2 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed higher by over 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders i
No Data